Pharmacists find themselves on the front lines of a growing public health challenge as measles cases surge nationwide. As ...
A SMART-design, pragmatic trial in 20,604 adults showed digital outreach improved 14-day statin refill rates versus usual ...
In "COVID-19 in 2026: Why the Virus Still Threatens Vulnerable Patients," moderator Jeff Goad, PharmD, MPH is joined by ...
Women showed consistently higher post-T2D mental health diagnoses, with the strongest signal in younger women, supporting ...
The FDA approved tirzepatide (Mounjaro) for lowering the risk of major adverse cardiovascular events (MACE) among adults with ...
The American Academy of Neurology (AAN) and American Headache Society (AHS) issued an updated practice guideline for the ...
Researchers identify the resources and opportunities available for community pharmacies to incorporate climate-conscious ...
Global pharmacy leaders aligned on four levers for durable primary care integration: workforce readiness, sustainable funding ...
The approval gives pharmacists a new nonTNF biologic option across both major forms of pediatric inflammatory bowel disease.
From the industry-wide efforts of major players in pharmacy to grassroots efforts at the local level, advocacy for the ...
Duane Jones, BS Pharm, and Jennifer Griffin, PharmD, share real-world examples of how pharmacists’ medication expertise is ...
The FDA added bemotrizinol to its OTC sunscreen monograph in June 2026, permitting the ingredient in US sunscreen formulations at concentrations up to 6%. The action, finalized 7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results